FDA Inspection 1145747 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Jul 1, 2021 in New Hyde Park, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 1, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- New Hyde Park, NY (United States)